LOJACONO, Andrea
 Distribuzione geografica
Continente #
NA - Nord America 7.809
EU - Europa 4.288
AS - Asia 3.704
SA - Sud America 652
AF - Africa 94
OC - Oceania 15
Continente sconosciuto - Info sul continente non disponibili 8
Totale 16.570
Nazione #
US - Stati Uniti d'America 7.690
CN - Cina 1.358
SG - Singapore 1.256
UA - Ucraina 812
DE - Germania 763
PL - Polonia 681
IT - Italia 597
BR - Brasile 548
HK - Hong Kong 416
FR - Francia 331
GB - Regno Unito 256
FI - Finlandia 249
RU - Federazione Russa 220
VN - Vietnam 181
TR - Turchia 135
IE - Irlanda 129
IN - India 109
EE - Estonia 93
BD - Bangladesh 73
MX - Messico 55
CA - Canada 41
SE - Svezia 37
ZA - Sudafrica 36
AR - Argentina 31
IQ - Iraq 25
BE - Belgio 21
EC - Ecuador 20
NL - Olanda 20
JP - Giappone 19
NG - Nigeria 19
ID - Indonesia 18
SA - Arabia Saudita 18
AU - Australia 14
PK - Pakistan 14
UZ - Uzbekistan 14
AT - Austria 13
ES - Italia 13
CO - Colombia 12
CL - Cile 10
EG - Egitto 9
EU - Europa 8
UY - Uruguay 8
VE - Venezuela 8
AE - Emirati Arabi Uniti 7
DZ - Algeria 7
JM - Giamaica 7
TH - Thailandia 7
CZ - Repubblica Ceca 6
IR - Iran 6
KZ - Kazakistan 6
JO - Giordania 5
MU - Mauritius 5
NP - Nepal 5
PE - Perù 5
PY - Paraguay 5
BG - Bulgaria 4
BH - Bahrain 4
HR - Croazia 4
LT - Lituania 4
MA - Marocco 4
RS - Serbia 4
AL - Albania 3
BO - Bolivia 3
BY - Bielorussia 3
CH - Svizzera 3
GR - Grecia 3
GT - Guatemala 3
HU - Ungheria 3
KG - Kirghizistan 3
LV - Lettonia 3
NI - Nicaragua 3
OM - Oman 3
PH - Filippine 3
PT - Portogallo 3
TN - Tunisia 3
TT - Trinidad e Tobago 3
AZ - Azerbaigian 2
DK - Danimarca 2
ET - Etiopia 2
HN - Honduras 2
KE - Kenya 2
KW - Kuwait 2
LA - Repubblica Popolare Democratica del Laos 2
LB - Libano 2
LK - Sri Lanka 2
LY - Libia 2
MY - Malesia 2
PS - Palestinian Territory 2
SI - Slovenia 2
SK - Slovacchia (Repubblica Slovacca) 2
SN - Senegal 2
AM - Armenia 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BW - Botswana 1
CG - Congo 1
CR - Costa Rica 1
DO - Repubblica Dominicana 1
GD - Grenada 1
Totale 16.559
Città #
Fairfield 815
Woodbridge 710
Singapore 692
Warsaw 678
Ashburn 609
Jacksonville 576
Houston 442
Hong Kong 410
Ann Arbor 344
Chandler 323
Cambridge 319
Seattle 302
San Jose 295
Wilmington 284
Beijing 282
The Dalles 247
Princeton 244
Nanjing 220
New York 205
Los Angeles 202
Buffalo 134
Helsinki 132
Dublin 129
Istanbul 112
Lauterbourg 107
Tallinn 93
Nanchang 83
Des Moines 67
Dearborn 66
Milan 63
Ho Chi Minh City 61
Moscow 60
São Paulo 60
Shenyang 56
Lancaster 53
Munich 53
Hebei 47
San Diego 46
Changsha 45
Rome 42
Shanghai 42
Brescia 38
Verona 37
Jinan 35
San Francisco 35
Tianjin 35
Hanoi 34
Dallas 31
Santa Clara 31
Jiaxing 29
Chennai 27
Chicago 27
Nürnberg 26
Hangzhou 25
Redondo Beach 23
London 22
Zhengzhou 22
Guangzhou 21
Brussels 20
Council Bluffs 20
Denver 20
Genova 20
Abuja 19
Phoenix 19
Tokyo 19
Dong Ket 18
Johannesburg 18
Orem 18
Taizhou 17
Rio de Janeiro 16
Naples 15
Belo Horizonte 14
Boardman 14
Ningbo 14
Brasília 13
Mexico City 13
Mumbai 13
Poplar 13
Tashkent 13
Turku 13
Brooklyn 12
Dhaka 12
Monterrey 12
Amsterdam 11
Baghdad 11
Guayaquil 11
Kunming 11
Lanzhou 11
Nuremberg 11
Toronto 11
Charlotte 10
Falkenstein 10
Manchester 10
Montreal 10
Porto Alegre 10
Riyadh 10
Auburn Hills 9
Boston 9
Florence 9
Ribeirão Preto 9
Totale 10.816
Nome #
Bambini pretermine: nati per vivere 363
Parto e puerperio: i vissuti delle donne in un'ottica di ricerca multidisciplinare. 329
Variabili psicologiche materne e andamento del parto: rilevazione in un campione di donne italiane alla prima esperienza di parto. 328
Mesenchymal stromal cells (MSCs) induce ex vivo proliferation and erythroid commitment of cord blood haematopoietic stem cells (CB-CD34+ cells) 326
EULAR recommendations for women's health and the management of family planning, assisted reproduction, pregnancy and menopause in patients with systemic lupus erythematosus and/or antiphospholipid syndrome 314
Percorso nascita: un progetto di ricerca multidisciplinare. 290
Long-term outcome of children of rheumatic disease patients 233
The role of second trimester uterine artery Doppler in pregnancies with systemic lupus erythematosus 210
L’approccio multidisciplinare alla nascita: parto, puerperio, visti dalle donne. 199
A comprehensive review of the clinical approach to pregnancy and systemic lupus erythematosus 190
First Report of the Italian Registry on Immune-Mediated Congenital Heart Block (Lu.Ne Registry) 189
Cerebroplacental ratio before induction of labour in normally grown fetuses at term and intrapartum fetal compromise 186
Dinoprostone per l'induzione del travaglio di parto in pazienti con Bishop score favorevole: confronto tra gel vaginale e pessario vaginale a rilascio prolungato 181
Children born to SLE and APS mothers 179
L’approccio multidisciplinare alla nascita: parto e puerperio visti dalle donne. 176
Systemic vasculitis and pregnancy: a multicenter study on maternal and neonatal outcome of 65 prospectively followed pregnancies 168
A randomized controlled trial of 24-hour vaginal dinoprostone pessary compared to gel for induction of labor in term pregnancies with a Bishop score 167
Thrombophilia is significantly associated with severe preeclampsia: results of a large-scale, case-controlled study 165
Brief Report: Successful pregnancies but a higher risk of preterm births in patients with systemic sclerosis: An Italian multicenter study 162
Uterine artery velocimetry in patients with gestational hypertension 160
Pregnancy implications for systemic lupus erythematosus and the antiphospholipid syndrome 160
The effects of lupus and antiphospholipid antibody syndrome on foetal outcomes 160
Prophylactic oral nifedipine to reduce preterm delivery: a randomized controlled trial in women at high risk 159
Labor course and delivery in epidural analgesia: a case-control study 157
Pregnancy in autoimmune rheumatic diseases: the importance of counselling for old and new challenges. 157
Pregnancy complications of the antiphospholipid syndrome 156
Correlation of fetal DNA levels in maternal plasma with Doppler status in pathological pregnancies 155
Risk factors for adverse maternal and fetal outcomes in women with confirmed aPL positivity: Results from a multicenter study of 283 pregnancies 154
Quantitative analysis of fetal DNA in maternal plasma in pathological conditions associated with placental abnormalities. 151
Subpopulations of anti-β₂glycoprotein I antibodies with different pathogenic potential: fine specificity against the domains of β₂glycoprotein I 150
Impact of in utero environment on the offspring of lupus patients 149
Long-term neurodevelopmental outcome of children born to prospectively followed pregnancies of women with systemic lupus erythematosus and/or antiphospholipid syndrome 147
Insulinoma Identified in Puerperium: Association with Pregnancy and Literature Review 146
Offspring of Women with Systemic Autoimmune diseases: fetal and neonatal complications and inheritance of autoimmune diseases. 146
Neuropsychological development of children born to patients with systemic lupus erythematosus 145
Autoimmunity and pregnancy: autoantibodies and pregnancy in rheumatic diseases 145
PROSPECTIVELY FOLLOWED PREGNANCIES IN PATIENTS WITH SYSTEMIC VASCULITIS: STILL MANY PROBLEMS ON BOTH FOETAL AND MATERNAL SIDE 144
Follow up of infants exposed to hydroxychloroquine given to mothers during pregnancy and lactation 143
Cerebral ultrasound abnormalities in infants born to mothers with autoimmune disease 143
Predictors of maternal and fetal complications in SLE patients: a prospective study 141
Risk of congenital complete heart block in newborns of mothers with anti-Ro/SSA antibodies detected by counterimmunoelectrophoresis: a prospective study of 100 women 141
Pregnancy outcome in 100 women with autoimmune diseases and anti-Ro/SSA antibodies: a prospective controlled study. 140
Neonatal outcome in patients with rheumatic disease 138
Idiopathic eosinophilic pneumonia and pregnancy: report of a case. 137
Anticardiolipin and anti-beta2 glycoprotein I antibodies in infants born to mothers with antiphospholipid antibody-positive autoimmune disease: a follow-up study 137
Neonatal effects of maternal antiphospholipid syndrome. 135
Immune system development in infants born to mothers with autoimmune disease, exposed in utero to immunosuppressive agents 134
European registry of babies born to mothers with antiphospholipid syndrome. 134
Atypical presentation and imaging features of postpartum posterior reversible encephalopathy syndrome 134
Systemic and fetal-maternal nitric oxide synthesis in normal pregnancy and in preeclampsia 133
Lupus and the antiphospholipid syndrome in pregnancy and obstetrics: clinical characteristics, diagnosis, pathogenesis, and treatment. 132
The Efficacy and Safety of Cyclosporin A in Pregnant Patients with Systemic Autoimmune Diseases 132
Infertility in women with systemic autoimmune diseases 132
Pregnancy and autoimmunity: maternal treatment and maternal disease influence on pregnancy outcome 131
Neuropsychological development of children born to patients with antiphospholipid syndrome. 130
Pregnancy and neonatal outcome in primary antiphospholipid syndrome. 128
Assistenza e sorveglianza nel travaglio di parto a basso rischio 127
The combination of short cervical length and phIGFBP-1 in the prediction of preterm delivery in symptomatic women. 126
Autoantibodies and prediction of reproductive failure. 126
Disease course and obstetric outcomes of pregnancies in juvenile idiopathic arthritis: are there any differences among disease subtypes? A single-centre retrospective study of prospectively followed pregnancies in a dedicated pregnancy clinic 125
Neonates born from mothers with autoimmune disorders 123
Anti-{beta}2-glycoprotein I IgG antibodies from 1-year-old healthy children born to mothers with systemic autoimmune diseases preferentially target domain 4/5: might it be the reason for their 'innocent' profile? 122
Complement Activation and Pregnancy Failure. 121
Variabili psicologiche materne e andamento clinico del parto 120
Maternal cardiovascular function in pregnancies complicated by intrauterine growth restriction 119
Transabdominal uterine arteries Doppler between 11-14 weeks of gestation for prediction of outcome in high risk pregnancies 119
Is it possible to differentiate "Natural" Antiphospholipid antibodies from "Thrombophilic" ones? Analysis of the fine specificity against the domains of Beta2glycoprotein I 117
Anti beta 2 glycoprotein I antibodies in a general obstetric population: preliminary results on the prevalence and correlation with pregnancy outcome 116
Labor induction with misoprostol vaginal insert compared with dinoprostone vaginal insert 116
Risk of congenital complete heart block in newborns of mothers with anti-Ro/SSA antibodies detected by counterimmunoelectrophoresis 115
Beta 2 glycoprotein I and placental anticoagulant protein I in placentae from patients with antiphospholipid syndrome 115
Correlation between fetal Doppler indices and neonatal acid–base status at birth in healthy appropriate for gestational age term fetuses 115
Autoimmune diseases and pregnancy 115
Pregnancy in systemic sclerosis: a prospective study 114
IgG anti-B2glycoprotein I antibodies form one-year-old children born to mothers with systemic autoimmune diseases preferentially target domain 4/5 113
An observational multicentre study on the efficacy and safety of assisted reproductive technologies in women with rheumatic diseases 113
External cephalic version for breech presentation at term: an effective procedure to reduce the caesarean section rate 110
THE FINE SPECIFICITY OF ANTI-BETA2GLYCOPROTEIN I ANTIBODIES IN SYSTEMIC AUTOIMMUNE DISEASES IS PREFERENTIALLY DIRECTED AGAINST DOMAIN 1 110
Esperienza personale nel trattamento delle emorragie gastroduodenali mediante l'associazione di somatostatina e ranitidina 109
Antiphospholipid and anti beta 2 glycoprotein I antibodies in patients with obstetrical complications 108
Outcome of infants from mothers with anti-SSA/Ro antibodies. 108
ANTICORPI ANTIFOSFOLIPIDI: E' POSSIBILE DISTINGUERE GLI ANTICORPI "INNOCENTI" DA QUELLI "TROMBOFILICI"? ANALISI DELLA FINE SPECIFICITA' DIRETTA VERSO I DOMINI DELLA BETA2GLICOPROTEINA I 108
LA FINE SPECIFICITA' DEGLI ANTICORPI ANTI-BETA2GLICOPROTEINA I NELLE MALATTIE AUTOIMMUNI SISTEMICHE E' PREVALENTEMENTE DIRETTA ERSO IL DOMINIO 1 108
Finespecificity of anti-B2glycoprotein I antibodies in sysemic autoimmune diseasesis mostly directed against domain 1 108
Systemic lupus erythematosus and pregnancy: a prospective study. 106
Gestational success in patients at risk of preterm labor with presence of ureaplasma urealyticum in cervico-vaginal secretions 105
Novel aspects of Sjögren’s syndrome in 2012 104
LONG TERM OUTCOME IN CHILDREN BORN TO MOTHERS WITH SYSTEMIC LUPUS ERYTEMATOSUS AND ANTIPHOSPHOLIPID SYNDROME 104
Triple antiphospholipid (aPL) antibodies positivity is associated with pregnancy complications in aPL carriers: A multicenter study on 62 pregnancies 104
Thrombophilia is a risk factor for severe preeclampsia and its recurrence 103
Obstetric manifestation of the Antiphospholipid Syndrome 101
ONE-YEAR-OLD CHILDREN BORN TO MOTHERS WITH SYSTEMIC AUTOIMMUNE DISEASES MAY DEVELOP ANTI-BETA2GPI IGG ANTIBODIES THAT PREFERENTIALLY TARGET DOMAIN 4/5 101
Prospectively-followed pregnancies in patients with inflammatory arthritis taking biological drugs: an Italian multicentre study. 101
Reproductive Issues and Pregnancy Implications in Systemic Sclerosis. 101
Streptococcus group B and pregnancy: the therapeutic role of topical intravaginal clindamycin 99
Contraception in adolescents with systemic lupus erythematosus 99
SICUREZZA DEI FARMACI BIOLOGICI ANTI-TNF IN GRAVIDANZA 99
One-year-old children born to mothers with systemic autoimmune diseases may develop anti-beta2GPI IGg antibodies that preferentially target domain 4/5 98
Clinical followup and screening for autoimmune disorders in patients with previous severe early onset preeclampsia 98
SAT0018 Neurodevelopmental Long Term Outcome in Children Born to Mothers with Systemic Lupus Erythematosus and Antiphospholipid Syndrome 96
Totale 14.536
Categoria #
all - tutte 73.837
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 73.837


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202165 0 0 0 0 0 0 0 0 0 0 0 65
2021/2022949 39 169 18 49 13 50 38 67 41 119 93 253
2022/20231.017 138 7 26 78 104 261 4 105 173 5 42 74
2023/2024859 75 27 50 71 36 158 33 37 217 15 2 138
2024/20252.102 9 26 14 342 213 198 177 85 199 134 431 274
2025/20264.066 377 596 397 577 357 262 615 125 228 342 140 50
Totale 16.795